1. Home
  2. MMS vs LGND Comparison

MMS vs LGND Comparison

Compare MMS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maximus Inc.

MMS

Maximus Inc.

HOLD

Current Price

$60.63

Market Cap

3.2B

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$238.06

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MMS
LGND
Founded
1975
1987
Country
United States
United States
Employees
N/A
68
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
1997
N/A

Fundamental Metrics

Financial Performance
Metric
MMS
LGND
Price
$60.63
$238.06
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$256.29
AVG Volume (30 Days)
723.3K
176.4K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
2.02%
N/A
EPS Growth
10.42
N/A
EPS
3.50
N/A
Revenue
$2,392,236,000.00
N/A
Revenue This Year
$0.44
$1.25
Revenue Next Year
$5.15
$19.41
P/E Ratio
$17.29
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$56.92
$103.43
52 Week High
$100.00
$247.38

Technical Indicators

Market Signals
Indicator
MMS
LGND
Relative Strength Index (RSI) 41.42 61.82
Support Level $56.92 $199.97
Resistance Level $63.26 $247.38
Average True Range (ATR) 1.99 7.00
MACD 0.18 1.15
Stochastic Oscillator 58.52 91.53

Price Performance

Historical Comparison
MMS
LGND

About MMS Maximus Inc.

Maximus Inc designs, develops, and delivers programs enabling people to access vital government services. It translates health and human services public policy into operating models that achieve outcomes for governments at scale. The company covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. The company operates through the following segments: U.S. Federal Services, U.S. Services, and Outside the U.S. A majority of its revenue is derived from the U.S. Federal Services segment, which engages with various U.S. federal government agencies to deliver clinical services, maintenance services, and technology solutions.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: